UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: B | C | F | G | H | J | K | L | M | N | P | R | T
Number of items: 26.

B

Bakhai, A; Fox, Z; Wang, D; (2002) Practical Issues in Trial Design. Clinical Researcher , 2 (8) pp. 32-35.

Blaxhult, A; Fox, Z; Colebunders, R; Francioli, P; Ben-Ishai, Z; Fatkenheuer, G; Parkin, JM; ... EuroSIDA Study Grp, E; + view all (2002) Regional and temporal changes in AIDS in Europe before HAART. EPIDEMIOL INFECT , 129 (3) 565 - 576. 10.1017/S0950268802007719. Green open access
file

C

Campbell, WB; Aitken, M; Tooke, JE; (2002) Expectations for the skills of final year medical students in examining lower limb arteries and veins. EUR J VASC ENDOVASC , 23 (3) 270 - 271. 10.1053/ejvs.2002.1596.

Cowen, R; Williams, KJ; Jaffar, M; Telfer, B; Garvey, D; Stratford, IJ; (2002) A novel human P450 reductase activated indolequinone prodrug for use in adenoviral mediated hypoxia selective gene therapy. Presented at: UNSPECIFIED.

Criddle, DN; Meireles, AVP; Macêdo, LB; Leal-Cardoso, JH; Scarparo, HC; Jaffar, M; (2002) Comparative inhibitory effects of niflumic acid and novel synthetic derivatives on the rat isolated stomach fundus. Journal of Pharmacy and Pharmacology , 54 (2) pp. 283-288. 10.1211/0022357021778321.

F

Fegan, PG; Macleod, KM; Tooke, JE; Shore, AC; (2002) n-3 NEFA: vascular implications. EUR HEART J , 23 (3) 185 - 187. 10.1053/euhj.2001.2945.

G

Gaisser, S; Martin, CJ; Wilkinson, B; Sheridan, RM; Lill, RE; Weston, AJ; Ready, SJ; ... Staunton, J; + view all (2002) Engineered biosynthesis of novel spinosyns bearing altered deoxyhexose substituents. CHEM COMMUN (6) 618 - 619.

Gooding, KM; Tooke, JE; Shore, AC; (2002) Assessment of microvascular filtration coefficent during early and late phase of the menstrual cycle in females not taking the oral contraceptive pill. J PHYSIOL-LONDON , 539 85P - 86P.

H

Hayler, JF; (2002) Novel 2,6-Disubstituted Purines – The Synthesis of Potent and Selective Inhibitors of the Protein Kinase Syk. Presented at: EFMC, Barcelona.

J

Jaffar, M; Cole, C; Gbaj, A; Reigan, P; Edwards, P; Freeman, S; Stratfrod, IJ; (2002) Novel nitroimidazoyluracil prodrug derivatives as tumour-selective inhibitors of the angiogenic enzyme thymidine phosphorylase. Presented at: UNSPECIFIED.

K

Kakkar, AK; Kadziola, Z; Williamson, RCN; Levine, MN; Low, V; Lemoine, NR; (2002) Low molecular weight heparin (LMWH) therapy and survival in advanced cancer. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 148A-148A). AMER SOC HEMATOLOGY

Khorsandi, SE; Kakkar, AK; (2002) Inhibition of tumour xenograft growth by targeting hypoxic gene expression. BRITISH JOURNAL OF SURGERY , 89 (5) pp. 635-636.

L

Lomas, DA; (2002) Chronic obstructive pulmonary disease center dot Introduction. THORAX , 57 (8) p. 735. 10.1136/thorax.57.8.735.

M

Mc Nally, V; Patterson, A; Williams, K; Cowen, R; Stratford, I; Jaffar, M; (2002) Antiangiogenic, Bioreductive and Gene Therapy Approaches to the Treatment of Hypoxic Tumours. Current Pharmaceutical Design , 8 (15) pp. 1319-1333. 10.2174/1381612023394548.

McNally, V; Jaffar, M; Freeman, S; Stratford, IJ; Bryce, R; (2002) In silico and flexible docking screening using bioavailability, similarity and energetic filters: application to human thymidine phosphorylase. Presented at: UNSPECIFIED.

Mrema, I; Williams, KJ; Wind, S; Patterson, AV; Phillips, RM; Stratford, IJ; Jaffar, M; (2002) Cytotoxic indolequinones as NQO1-directed tumour-specific bioreductive prodrugs. Presented at: UNSPECIFIED.

Murray, PE; McNally, VA; Lockyer, SD; Williams, KJ; Stratford, IJ; Jaffar, M; Freeman, S; (2002) Synthesis and enzymatic evaluation of pyridinium-Substituted uracil derivatives as novel inhibitors of thymidine phosphorylase. Bioorganic & Medicinal Chemistry , 10 (3) pp. 525-530. 10.1016/S0968-0896(01)00309-1.

Myers, LB; Frost, S; (2002) Smoking and smoking cessation: modifying perceptions of risk. In: Rutter, D and Quine, L, (eds.) Changing Health Behaviour. (pp. 66-86). OUP: Buckingham.

N

Nabuurs-Franssen, MH; Houben, AJHM; Tooke, JE; Schaper, NC; (2002) The effect of polyneuropathy on foot microcirculation in Type II diabetes. DIABETOLOGIA , 45 (8) 1164 - 1171. 10.1007/s00125-002-0872-z.

Nakamya, A; Stratford, IJ; Freeman, S; Jaffar, M; (2002) The synthesis of hypoxia-selective nitroaromatic compounds as bioreductive drug delivery agents. Presented at: UNSPECIFIED.

Nash, GF; Chopada, A; Eccles, S; Swift, RI; Sculley, MF; Kakkar, AK; (2002) Endostatin is released from human platelets. BRITISH JOURNAL OF SURGERY , 89 (5) p. 662.

P

Parker, C; Jaffar, M; Williams, KJ; Robertson, N; Harris, AL; Stratford, IJ; (2002) Characterisation of CA-IX expression and activity in human tumour cell lines. Presented at: UNSPECIFIED.

Patel, HB; Lall, DG; Nasir, FA; Kakkar, AK; (2002) Blood products have increased angiogenesis stimulating effects following storage. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 282A-283A). AMER SOC HEMATOLOGY

Patel, HB; Nasir, FA; Nash, GF; Kakkar, AK; (2002) The increase in pro-angiogenic potential of recipient blood following blood transfusion. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 26A-26A). AMER SOC HEMATOLOGY

R

Robinson, I; Jaffar, M; Wind, NS; Williams, KJ; Stratford, IJ; (2002) Indolequinone carbamate prodrugs of mustards as hypoxia-selective cytotoxins. Presented at: UNSPECIFIED.

T

Thodiyil, P; Kakkar, AK; (2002) Can low-molecular-weight heparins improve outcome in patients with cancer? CANCER TREATMENT REVIEWS , 28 (3) pp. 151-155. 10.1016/S0305-7372(02)00040-3.

This list was generated on Sun Jun 17 02:49:26 2018 BST.